Heat Shock Proteins, Autoimmunity, and Cancer Treatment
Open Access
- 1 January 2012
- journal article
- review article
- Published by Wiley in Autoimmune Diseases
- Vol. 2012, 1-10
Abstract
Heat shock proteins (HSPs) have been linked to the therapy of both cancer and inflammatory diseases, approaches that utilize contrasting immune properties of these proteins. It would appear that HSP family members Hsp60 and Hsp70, whether from external sources or induced locally during inflammation, can be processed by antigen-presenting cells and that HSP-derived epitopes then activate regulatory T cells and suppress inflammatory diseases. These effects also extend to the HSP-rich environments of cancer cells where elevated HSP concentrations may participate in the immunosuppressive tumor milieu. However, HSPs can also be important mediators of tumor immunity. Due to their molecular chaperone properties, some HSPs can bind tumor-specific peptides and deliver them deep into the antigen-processing pathways of antigen-presenting cells (APCs). In this context, HSP-based vaccines can activate tumor-specific immunity, trigger the proliferation and CTL capabilities of cancer-specific CD8+ T cells, and inhibit tumor growth. Further advances in HSP-based anticancer immunotherapy appear to involve improving the properties of the molecular chaperone vaccines by enhancing their antigen-binding properties and combating the immunosuppressive tumor milieu to permit programming of active CTL capable of penetrating the tumor milieu and specifically targeting tumor cells.Keywords
Funding Information
- National Institutes of Health (RO1CA047407, RO1CA119045, RO1CA094397)
- National Institutes of Health (RO1CA047407, RO1CA119045, RO1CA094397)
- National Institutes of Health (RO1CA047407, RO1CA119045, RO1CA094397)
- Beth Israel Deaconess Medical Center (RO1CA047407, RO1CA119045, RO1CA094397)
This publication has 103 references indexed in Scilit:
- Inducible Heat Shock Protein 70 Reduces T Cell Responses and Stimulatory Capacity of Monocyte-derived Dendritic CellsJournal of Biological Chemistry, 2012
- Molecular chaperones in mammary cancer growth and breast tumor therapyJournal of Cellular Biochemistry, 2011
- Heat shock protein 90 (HSP90) contributes to cytosolic translocation of extracellular antigen for cross-presentation by dendritic cellsProceedings of the National Academy of Sciences, 2011
- Distinguishing integral and receptor-bound heat shock protein 70 (Hsp70) on the cell surface by Hsp70-specific antibodiesCell Stress and Chaperones, 2011
- A Mage3/Heat Shock Protein70 DNA vaccine induces both innate and adaptive immune responses for the antitumor activityVaccine, 2009
- Secretion of stress protein grp170 promotes immune-mediated inhibition of murine prostate tumorCancer Immunology, Immunotherapy, 2009
- Cancer-related inflammationNature, 2008
- Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunityNature Reviews Immunology, 2004
- The many important facets of T-cell repertoire diversityNature Reviews Immunology, 2004
- Molecular identification of a danger signal that alerts the immune system to dying cellsNature, 2003